Some studies found higher CSF levels of TREM2 in AD [176,177,178,179] and MCI [176] compared to controls, and in subjects with MCI due to AD (or prodromal AD) compared with preclinical AD and AD dementia patients (Table 2) [179]. This evidence concerns the gene TREM2 and Alzheimer disease.